Vas Narasimhan (Photographer: Simon Dawson/Bloomberg via Getty Images) and Severin Schwan (Roche)
Roche ends a bad, no good, plain lousy week with a $0 co-pay copycat stalking one of its blockbusters
Roche is ending the week with another dispiriting setback to reflect on.
Right on the heels of its big TIGIT Phase III fail, which rattled …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
